1- (4- bromobenzoyl)piperazine- 2,3- dicarboxylic acid
structure given in first source
Also Known As:
1-BBPD; PBB-PZDA
Networked: 3
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Related Diseases
1. | Seizures (Absence Seizure)
04/19/1985
- " In DBA/2 mice, pBB-PzDA (0.01 mumol i.c.v.) or pCB-PzDA (0.03 mumol i.c.v.) protects against the clonic and tonic seizures induced by loud sound. " 04/07/1987
- " gamma-D-GAMS, 0.025 and 0.5 mumol, and pBB-PzDA, 0.1 mumol, blocked myoclonic seizures induced by kainate in the presence of 2-amino-7-phosphonoheptanoate, a selective antagonist at the NMDA receptor, with potency comparable to that for antagonism of seizures produced by kainate alone. " 04/07/1987
- " gamma-D-GAMS, 0.0025-1.0 mumol, and pBB-PzDA, 0.001-0.2 mumol, were preferentially active against myoclonic seizures induced by kainate, but had also pronounced anticonvulsant action against NMDA. "
|
2. | Ganglion Cysts (Ganglion)
|
3. | Epilepsy (Aura)
|
|
Related Drugs and Biologics